Original Article

You have full text access to this OnlineOpen article

Cognitive effects of hormone therapy in men with prostate cancer

A Review

  1. Christian J. Nelson PhD1,†,*,
  2. Jennifer S. Lee BS2,
  3. Maria C. Gamboa BA1,
  4. Andrew J. Roth MD1

Article first published online: 29 JUL 2008

DOI: 10.1002/cncr.23658

Issue

Cancer

Cancer

Volume 113, Issue 5, pages 1097–1106, 1 September 2008

Additional Information

How to Cite

Nelson, C. J., Lee, J. S., Gamboa, M. C. and Roth, A. J. (2008), Cognitive effects of hormone therapy in men with prostate cancer. Cancer, 113: 1097–1106. doi: 10.1002/cncr.23658

Author Information

  1. 1

    Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York

  2. 2

    School of Medicine, Stony Brook University-State University of New York, Stony Brook, New York

  1. †

    Fax: (212) 888-0000

*Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, 641 Lexington Avenue, New York, NY 10022

Publication History

  1. Issue published online: 20 AUG 2008
  2. Article first published online: 29 JUL 2008
  3. Manuscript Accepted: 13 MAR 2008
  4. Manuscript Revised: 25 FEB 2008
  5. Manuscript Received: 11 DEC 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

REFERENCES

  • 1
    Rashid MH,Chaudhary UB. Intermittent androgen deprivation therapy for prostate cancer. Oncologist. 2004; 9: 295–301.
  • 2
    Miyamoto H,Messing EM,Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate. 2004; 61: 332–353.
    Direct Link:
  • 3
    Loblaw DA,Virgo KS,Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007; 25: 1596–1605.
  • 4
    Pomerantz M,Kantoff P. Advances in the treatment of prostate cancer. Annu Rev Med. 2007; 58: 205–220.
  • 5
    Barrass BJ,Thurairaja R,Persad RA. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer. BJU Int. 2004; 93: 1175–1176.
  • 6
    Bolla M,Collette L,Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. [see comment]. Lancet. 2002; 360: 103–106.
  • 7
    Bolla M,de Reijke TM,Zurlo A,Collette L. Adjuvant hormone therapy in locally advanced and localized prostate cancer: 3 EORTC trials. Front Radiat Ther Oncol. 2002; 36: 81–86.
  • 8
    Holzbeierlein JM,Castle E,Thrasher JB. Complications of androgen deprivation therapy: prevention and treatment. Oncology (Huntington). 2004; 18: 303–309; discussion 310.
  • 9
    Herr HW,O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000; 163: 1743–1746.
  • 10
    Thompson CA,Shanafelt TD,Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003; 8: 474–487.
  • 11
    Keating NL,O'Malley AJ,Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006; 24: 4448–4456.
  • 12
    D'Amico AV,Denham JW,Crook J, et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007; 25: 2420–2425.
  • 13
    Salminen EK,Portin RI,Koskinen A,Helenius H,Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Care Res. 2004; 10: 7575–7582.
  • 14
    Sherwin BB. Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci. 2003; 20: 385–393.
  • 15
    Plymate SR,Tenover JS,Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated nonsex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl. 1989; 10: 366–371.
  • 16
    Sherwin BB. Estrogen and cognitive functioning in men with mild cognitive impairment. J Mol Neurosci. 2002; 19: 219–223.
  • 17
    Cherrier MMM. Androgens and cognitive function. J Endocrinologic Invest. 2005; 28 ( 3 suppl ): 65–75.
  • 18
    Naftolin F,Ryan KJ,Davies IJ, et al. The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res. 1975; 31: 295–319.
  • 19
    Cherrier MM,Plymate S,Mohan S, et al. Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men. Psychoneuroendocrinology. 2004; 29: 65–82.
  • 20
    Yaffe K. Testosterone and the brain: uncharted territory [letter]. Lancet Neurol. 2004; 3: 270.
  • 21
    Yaffe K,Grady D,Pressman A,Cummings S. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. [see comment]. J Am Geriatr Soc. 1998; 46: 816–821.
  • 22
    Wefel JS,Kayl AE,Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer. 2004; 90: 1691–1696.
  • 23
    Yaffe K,Lui LY,Zmuda J,Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002; 50: 707–712.
    Direct Link:
  • 24
    Yaffe K,Edwards ER,Lui LY,Zmuda JM,Ferrell RE,Cauley JA. Androgen receptor CAG repeat polymorphism is associated with cognitive function in older men. Biol Psychiatry. 2003; 54: 943–946.
  • 25
    Sandstrom NJ,Kim JH,Wasserman MA. Testosterone modulates performance on a spatial working memory task in male rats. Horm Behav. 2006; 50: 18–26.
  • 26
    Leranth C,Petnehazy O,MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003; 23: 1588–1592.
  • 27
    MacLusky NJ,Hajszan T,Prange-Kiel J,Leranth C. Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006; 138: 957–965.
  • 28
    Edinger KL,Frye CA. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci. 2004; 118: 1352–1364.
  • 29
    Frye CA,Edinger KL,Seliga AM,Wawrzycki JM. 5alpha-reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology. 2004; 29: 1019–1027.
  • 30
    Daniel JM,Winsauer PJ,Moerschbaecher JM. Castration in rats impairs performance during acquisition of a working memory task and exacerbates deficits in working memory produced by scopolamine and mecamylamine. Psychopharmacology (Berlin). 2003; 170: 294–300.
  • 31
    Gibbs RB. Testosterone and estradiol produce different effects on cognitive performance in male rats. Horm Behav. 2005; 48: 268–277.
  • 32
    Bimonte-Nelson HA,Singleton RS,Nelson ME, et al. Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats. Exp Neurol. 2003; 181: 301–312.
  • 33
    Johnson RT,Burk JA. Effects of gonadectomy and androgen supplementation on attention in male rats. Neurobiol Learn Mem. 2006; 85: 219–227.
  • 34
    Leonard ST,Moerschbaecher JM,Winsauer PJ. Testosterone potentiates scopolamine-induced disruptions of nonspatial learning in gonadectomized male rats. Exp Clin Psychopharmacol. 2007; 15: 48–57.
  • 35
    Flood JF,Farr SA,Kaiser FE,La Regina M,Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav. 1995; 57: 669–673.
  • 36
    Harman SM,Metter EJ,Tobin JD,Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001; 86: 724–731.
  • 37
    Alexandersen P,Christiansen C. The aging male: testosterone deficiency and testosterone replacement. An up-date. Atherosclerosis. 2004; 173: 157–169.
  • 38
    Hampson E. Spatial cognition in humans: possible modulation by androgens and estrogens. J Psychiatry Neurosci. 1995; 20: 397–404.
  • 39
    Barrett-Connor E,Goodman-Gruen D,Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999; 84: 3681–3685.
  • 40
    Hogervorst E,De Jager C,Budge M,Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004; 29: 405–421.
  • 41
    Carlson LE,Sherwin BB. Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause. 2000; 7: 168–177.
  • 42
    Janowsky JS,Chavez B,Orwoll E. Sex steroids modify working memory. J Cognitive Neurosci. 2000; 12: 407–414.
  • 43
    Alexander GM,Swerdloff RS,Wang C, et al. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav. 1998; 33: 85–94.
  • 44
    Wolf OT,Preut R,Hellhammer DH,Kudielka BM,Schurmeyer TH,Kirschbaum C. Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. Biol Psychiatry. 2000; 47: 650–654.
  • 45
    Cherrier MM,Asthana S,Plymate S, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001; 57: 80–88.
  • 46
    Cherrier MM,Matsumoto AM,Amory JK, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005; 64: 290–296.
  • 47
    Cherrier MM,Matsumoto AM,Amory JK, et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology. 2007; 32: 72–79.
  • 48
    Green HJ,Pakenham KI,Headley BC, et al. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. [see comment]. BJU Int. 2002; 90: 427–432.
    Direct Link:
  • 49
    Cherrier MM,Rose AL,Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. [see comment]. J Urol. 2003; 170: 1808–1811.
  • 50
    Almeida OP,Waterreus A,Spry N,Flicker L,Martins RN. One-year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory, and depression in men. Psychoneuroendocrinology. 2004; 29: 1071–1081.
  • 51
    Salminen EK,Portin RI,Koskinen AI,Helenius HY,Nurmi MJ. Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer. 2005; 103: 1381–1387.
    Direct Link:
  • 52
    Bussiere JR,Beer TM,Neiss MB,Janowsky JS. Androgen deprivation impairs memory in older men. Behav Neurosci. 2005; 119: 1429–1437.
  • 53
    Beer TM,Bland LB,Bussiere JR, et al. Testosterone loss and estradiol administration modify memory in men. J Urol. 2006; 175: 130–135.
  • 54
    Jenkins VA,Bloomfield DJ,Shilling VM,Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int. 2005; 96: 48–53.
  • 55
    Joly F,Alibhai SM,Galica J, et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol. 2006; 176 (6 pt 1): 2443–2447.
  • 56
    Correa D,Ahles T. Cognitive adverse effects of chemotherapy in breast cancer patients. Curr Opin Support Palliat Care. 2007; 1: 57–62.
View Full Article (HTML) Get PDF (110K)